TRC8 Antibodies

Santa Cruz Biotechnology delivers a wide array of TRC8 monoclonal antibodies for research focused on understanding TRC8 protein functions. TRC8 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TRC8, also known as TBC1D20, is an E3 ubiquitin ligase that plays a critical role in the regulation of protein degradation and cellular homeostasis. TRC8 is involved in various cellular processes, including endoplasmic reticulum-associated degradation (ERAD) and the modulation of cellular signaling pathways. Research has shown that TRC8 has significant implications in diseases such as cancer and neurodegenerative disorders. Investigating TRC8 functions can provide valuable insights into cellular protein quality control mechanisms. Understanding TRC8's role in protein degradation pathways may reveal new therapeutic targets for disease treatment. Exploring TRC8's involvement in cellular signaling networks can enhance knowledge of disease progression mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of TRC8's role in health and disease.